Javascript must be enabled to continue!
COVID impact on pattern of ischemic heart disease in comparable period
View through CrossRef
Aim: To compare the impact of COVID-19 on pattern of Ischemic Heart Disease in comparable period by assessing the incidence, severity of symptoms and in-hospital mortality of Ischemic Heart Disease patients before and during COVID-19. Background: COVID-19 directly or indirectly, affects the cardiovascular system it not only causes myocardial injury but also reduces the incidence and increasing the severity and mortality of Ischemic Heart Disease patients and it was seen that pneumonia and influenza infections increases the risk of acute MI by six folds. Methods: Data collected from health records of patients admitted in National Heart Institute from Ischemic Heart Disease in comparable four months period of before (Oct 2019-Jan 2020) and during (Oct 2020-Jan 2021)COVID-19 by using a self-structured bio physiological tool. The total samples taken were 421 out of which 237 were before COVID-19 and 184 were during COVID-19. STARD checklist used to report the study. Results: The major findings of the study reveals that incidence of ischemic heart disease indicates that before COVID-19 incidence was 13.32% whereas the incidence of ischemic heart disease during COVID-19 was 12.69%. This means incidence decreases during COVID-19 as compared to before COVID-19. Severity scores measured before COVID-19 showed the majority of the patient (61.2%) having no severity as compared to during COVID-19 whereas the majority of patients having mild (41.8%) and moderate (1.1%) severity as compared to before COVID-19. Mortality of ischemic heart disease indicates that before COVID-19 in-hospital mortality was 1.28% whereas in-hospital mortality of ischemic heart disease during COVID-19 was 0.54%. Conclusion: From findings the study interprets that incidence and in-hospital mortality of Ischemic Heart Disease patients decreases during COVID-19 as compared to before COVID-19, whereas the severity of Ischemic Heart Disease symptoms increases during COVID-19 as compared to before COVID-19. Implication: Patients are staying away from the hospital due to fear of contracting the infection which in return act as a major issue of increasing Ischemic Heart Disease severity so, the nurses should involve in a proactive campaign to alleviate patient concern and encourage them to seek timely medical attention despite the COVID-19 pandemic.
Title: COVID impact on pattern of ischemic heart disease in comparable period
Description:
Aim: To compare the impact of COVID-19 on pattern of Ischemic Heart Disease in comparable period by assessing the incidence, severity of symptoms and in-hospital mortality of Ischemic Heart Disease patients before and during COVID-19.
Background: COVID-19 directly or indirectly, affects the cardiovascular system it not only causes myocardial injury but also reduces the incidence and increasing the severity and mortality of Ischemic Heart Disease patients and it was seen that pneumonia and influenza infections increases the risk of acute MI by six folds.
Methods: Data collected from health records of patients admitted in National Heart Institute from Ischemic Heart Disease in comparable four months period of before (Oct 2019-Jan 2020) and during (Oct 2020-Jan 2021)COVID-19 by using a self-structured bio physiological tool.
The total samples taken were 421 out of which 237 were before COVID-19 and 184 were during COVID-19.
STARD checklist used to report the study.
Results: The major findings of the study reveals that incidence of ischemic heart disease indicates that before COVID-19 incidence was 13.
32% whereas the incidence of ischemic heart disease during COVID-19 was 12.
69%.
This means incidence decreases during COVID-19 as compared to before COVID-19.
Severity scores measured before COVID-19 showed the majority of the patient (61.
2%) having no severity as compared to during COVID-19 whereas the majority of patients having mild (41.
8%) and moderate (1.
1%) severity as compared to before COVID-19.
Mortality of ischemic heart disease indicates that before COVID-19 in-hospital mortality was 1.
28% whereas in-hospital mortality of ischemic heart disease during COVID-19 was 0.
54%.
Conclusion: From findings the study interprets that incidence and in-hospital mortality of Ischemic Heart Disease patients decreases during COVID-19 as compared to before COVID-19, whereas the severity of Ischemic Heart Disease symptoms increases during COVID-19 as compared to before COVID-19.
Implication: Patients are staying away from the hospital due to fear of contracting the infection which in return act as a major issue of increasing Ischemic Heart Disease severity so, the nurses should involve in a proactive campaign to alleviate patient concern and encourage them to seek timely medical attention despite the COVID-19 pandemic.
Related Results
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
GENETIC PERSPECTIVE OF THE CONGENITAL HEART DISEASE
Congenital heart diseases (CHDs) are the structural abnormalities that may occur in the heart, greater veins and arteries or may include the septum between the ventricles and atria...
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
Comparative Characterization of Candidate Molecular Markers in Ischemic and Hemorrhagic Stroke
According to epidemiological studies, the leading cause of morbidity, disability and mortality are cerebrovascular diseases, in particular ischemic and hemorrhagic strokes. In rece...
COVID-19 PANDEMIC AND MANAGEMENT OF HYPERTENSION
COVID-19 PANDEMIC AND MANAGEMENT OF HYPERTENSION
Dear Editor,
In December 2019, a new virus which is known as SARS-COV-2 (COVID-19) was identified. In a short period, this virus spread rapidly and caused significant morbidities a...
Characterization and prognostic impact of ischemic etiology in heart failure with reduced left ventricular ejection fraction
Characterization and prognostic impact of ischemic etiology in heart failure with reduced left ventricular ejection fraction
Abstract
Introduction and objectives
Ischemic heart disease is the cause of 50-60% of cases of heart failure with reduced left v...
COVID-19: How Many Years of Life Lost?
COVID-19: How Many Years of Life Lost?
AbstractBackgroundCOVID-19 was the leading cause of death in the United States over the three-month period March through May 2020. Another perspective is COVID-19’s toll in terms o...
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
Using Primary Care Text Data and Natural Language Processing to Monitor COVID-19 in Toronto, Canada
Using Primary Care Text Data and Natural Language Processing to Monitor COVID-19 in Toronto, Canada
AbstractObjectiveTo investigate whether a rule-based natural language processing (NLP) system, applied to primary care clinical text data, can be used to monitor COVID-19 viral act...
Possible involvement of Poly (ADP-ribose) polymerase (PARP) in the cardioprotective potential of ischemic postconditioning in rat heart
Possible involvement of Poly (ADP-ribose) polymerase (PARP) in the cardioprotective potential of ischemic postconditioning in rat heart
Objective
The present study has been designed to investigate the possible role of Poly (ADP-ribose) polymerase (PARP) and protein kinase C-delta (PKC-δ) in myocar...


